![]() Quanterix Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches. | ![]() Olink Olink Proteomics is a company providing products and services for human protein biomarker discovery. | IMIDomics IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients. | |
Founding Date | Founding Date 2007 | Founding Date 2004 | Founding Date 2015 |
Type | Type Public | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Billerica, US HQ Baltimore, US Philadelphia, US San Diego, US San Francisco, US Seattle, US | Locations Uppsala, SE HQ Barcelona, ES Uppsala, SE Watertown, US | Locations HQ |
Employees | Employees 24840% increase | Employees 582 | Employees 3 |
Financial | |||
Revenue (est.) | Revenue (est.) $138.9m (FY, 2025) | Revenue (est.) $169.6m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods $73.9m (FY, 2025) | Cost of goods $51.9m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit $65m (FY, 2025) | Gross profit $119.9m (FY, 2023) | Gross profit N/A |
Net income | Net income ($107.2m) (FY, 2025) | Net income ($31.6m) (FY, 2023) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 96.5m | Total funding raised N/A | Total funding raised $ 16.5m |

Olink Proteomics is a company providing products and services for human protein biomarker discovery.
View companyIMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients.
View company